Literature DB >> 22684574

Implications of Th1 and Th17 cells in pathogenesis of oral lichen planus.

Sanxiang Xie1, Lei Ding1, Zhigang Xiong2, Shengrong Zhu3.   

Abstract

Oral lichen planus (OLP) is considered a T cell-mediated autoimmune disease with unknown aetiology. T helper cells appear to play an important role in the pathogenesis of OLP. We investigated the possible role of T helper cells, Th1 and Th17, in the lesions and circulation of patients with OLP. Forty patients with OLP and 15 healthy volunteers were recruited. Double immunofluorescence staining was used to detect Th1 and Th17 cells in the OLP lesions, and intracellular cytokine staining and flow cytometry to evaluate the proportion of Th1 and Th17 cells in peripheral blood. The levels of serum interferon (IFN)-γ and interleukin (IL)-17 were assessed by using an enzyme-linked immunosorbent assay. It was found that Th17 cells, as well as Th1 cells, were present in OLP lesions. The proportion of peripheral Th1 and Th17 cells was significantly increased in patients with OLP. The proportion of Th17 cells in atrophic-erosive OLP was elevated as compared with that in reticular OLP. Serum IL-17 levels in OLP patients were significantly higher than in controls, and those in the atrophic-erosive OLP group were increased as compared with the reticular OLP group. However, the levels of serum IFN-γ were slightly decreased in OLP patients. Our data suggested that Th1 and Th17 cells in the local lesions and peripheral blood may be associated with the pathogenesis of OLP, and that IL-17 may be an important proinflammatory cytokine in OLP. These findings enhance our understanding of OLP pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22684574     DOI: 10.1007/s11596-012-0078-7

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  29 in total

1.  Lack of clinicopathologic correlation in the diagnosis of oral lichen planus based on the presently available diagnostic criteria and suggestions for modifications.

Authors:  E H van der Meij; I van der Waal
Journal:  J Oral Pathol Med       Date:  2003-10       Impact factor: 4.253

2.  Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells.

Authors:  Ingunn M Stromnes; Lauren M Cerretti; Denny Liggitt; Robert A Harris; Joan M Goverman
Journal:  Nat Med       Date:  2008-02-17       Impact factor: 53.440

3.  Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells.

Authors:  Susanne J Szabo; Brandon M Sullivan; Claudia Stemmann; Abhay R Satoskar; Barry P Sleckman; Laurie H Glimcher
Journal:  Science       Date:  2002-01-11       Impact factor: 47.728

4.  Distribution of interleukin-2, -4, -10, tumour necrosis factor-alpha and transforming growth factor-beta mRNAs in oral lichen planus.

Authors:  C Simark-Mattsson; G Bergenholtz; M Jontell; C Eklund; G J Seymour; P B Sugerman; N W Savage; U I Dahlgren
Journal:  Arch Oral Biol       Date:  1999-06       Impact factor: 2.633

5.  Distribution of Th17 cells and FoxP3(+) regulatory T cells in tumor-infiltrating lymphocytes, tumor-draining lymph nodes and peripheral blood lymphocytes in patients with gastric cancer.

Authors:  Takanori Maruyama; Koji Kono; Yoshiki Mizukami; Yoshihiko Kawaguchi; Kousaku Mimura; Mitsuaki Watanabe; Shinichirou Izawa; Hideki Fujii
Journal:  Cancer Sci       Date:  2010-09       Impact factor: 6.716

6.  Increased Th17 cells are accompanied by FoxP3(+) Treg cell accumulation and correlated with psoriasis disease severity.

Authors:  Li Zhang; Xue-Qin Yang; Juan Cheng; Rang-Song Hui; Tian-Wen Gao
Journal:  Clin Immunol       Date:  2009-12-16       Impact factor: 3.969

7.  Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis.

Authors:  H Yamada; Y Nakashima; K Okazaki; T Mawatari; J-I Fukushi; N Kaibara; A Hori; Y Iwamoto; Y Yoshikai
Journal:  Ann Rheum Dis       Date:  2007-12-06       Impact factor: 19.103

Review 8.  Lichenoid tissue reaction/interface dermatitis: clinical and histological perspectives.

Authors:  Richard D Sontheimer
Journal:  J Invest Dermatol       Date:  2009-02-26       Impact factor: 8.551

Review 9.  The pathogenesis of oral lichen planus.

Authors:  P B Sugerman; N W Savage; L J Walsh; Z Z Zhao; X J Zhou; A Khan; G J Seymour; M Bigby
Journal:  Crit Rev Oral Biol Med       Date:  2002

10.  Phenotypic and functional features of human Th17 cells.

Authors:  Francesco Annunziato; Lorenzo Cosmi; Veronica Santarlasci; Laura Maggi; Francesco Liotta; Benedetta Mazzinghi; Eliana Parente; Lucia Filì; Simona Ferri; Francesca Frosali; Francesco Giudici; Paola Romagnani; Paola Parronchi; Francesco Tonelli; Enrico Maggi; Sergio Romagnani
Journal:  J Exp Med       Date:  2007-07-16       Impact factor: 14.307

View more
  11 in total

1.  Salivary expression of lncRNA DQ786243 and IL-17 in oral lichen planus: case-control study.

Authors:  Engy Abdeldayem; Laila Rashed; Shereen Ali
Journal:  BMC Oral Health       Date:  2022-06-18       Impact factor: 3.747

2.  Overexpression and selectively regulatory roles of IL-23/IL-17 axis in the lesions of oral lichen planus.

Authors:  Rui Lu; Xin Zeng; Qi Han; Mu Lin; Long Long; Hongxia Dan; Gang Zhou; Qianming Chen
Journal:  Mediators Inflamm       Date:  2014-07-08       Impact factor: 4.711

3.  Preliminary analysis of salivary microbiome and their potential roles in oral lichen planus.

Authors:  Kun Wang; Wenxin Lu; Qichao Tu; Yichen Ge; Jinzhi He; Yu Zhou; Yaping Gou; Joy D Van Nostrand; Yujia Qin; Jiyao Li; Jizhong Zhou; Yan Li; Liying Xiao; Xuedong Zhou
Journal:  Sci Rep       Date:  2016-03-10       Impact factor: 4.379

4.  Immune mechanisms involved in the coexistence of oral lichen planus and autoimmune thyroid diseases.

Authors:  Yahui Wang; Yilong Hao; Fan Tang; Qianming Chen
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-04-25

5.  Elevated Serum Interleukin-23 Levels in Patients with Oral and Cutaneous Lichen Planus.

Authors:  Maryam Mardani; Hossein Mofidi; Ladan Dastgheib; Sara Ranjbar; Nasrin Hamidizadeh
Journal:  Mediators Inflamm       Date:  2021-07-12       Impact factor: 4.711

6.  Serum Level of Interleukin 17 in Patients with Erosive and Non erosive Oral Lichen Planus.

Authors:  Firoz Pouralibaba; Zohre Babaloo; Farzaneh Pakdel; Marziye Aghazadeh
Journal:  J Dent Res Dent Clin Dent Prospects       Date:  2013-05-30

7.  Activation of myeloid dendritic cells, effector cells and regulatory T cells in lichen planus.

Authors:  Rosana Domingues; Gabriel Costa de Carvalho; Valéria Aoki; Alberto José da Silva Duarte; Maria Notomi Sato
Journal:  J Transl Med       Date:  2016-06-10       Impact factor: 5.531

8.  Association of genetic polymorphisms in interferon-γ, interleukin-6 and transforming growth factor-β1 gene with oral lichen planus susceptibility.

Authors:  Maha Ali M Al-Mohaya; Lubna Al-Otaibi; Fahad Al-Harthi; Ebtissam Al Bakr; Misbahul Arfin; Abdulrahman Al-Asmari
Journal:  BMC Oral Health       Date:  2016-08-20       Impact factor: 2.757

9.  Increased Serum Level and High Tissue Immunoexpression of Interleukin 17 in Cutaneous Lichen Planus: A Novel Therapeutic Target for Recalcitrant Cases?

Authors:  Magdalena Żychowska; Aleksandra Batycka-Baran; Wojciech Baran
Journal:  Dis Markers       Date:  2020-07-24       Impact factor: 3.434

Review 10.  Possible Mechanisms Involved in the Cooccurrence of Oral Lichen Planus and Hashimoto's Thyroiditis.

Authors:  Peiyao Wu; Shuhan Luo; Tao Zhou; Rui Wang; Xuemei Qiu; Peiyang Yuan; Yuqing Yang; Qi Han; Lu Jiang
Journal:  Mediators Inflamm       Date:  2020-02-04       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.